Why being an outsider can be a competitive advantage

Why being an outsider can be a competitive advantage

A big break in my career came unexpectedly. I had just been promoted to CEO of European operations for the H.J. Heinz Company when I was asked to join the board of directors for AstraZeneca. I was flattered but surprised to say the least – I had no experience in healthcare and limited knowledge of the pharmaceutical industry.

I thought about saying no, but my big break came when I said yes.

Why? That board position opened my eyes to the importance of healthcare, the impact it has on the world, and my passion for it. I immediately became fascinated with the way the industry operates: huge investments in high-risk R&D, complex science backed by reams of data, and results that are measured by how well products enhance the quality of life of real people.

I spent five years on that board. The experience made it clear to me that my next move would be toward healthcare, where I could also leverage my background in consumer packaged goods. When Novartis offered me the job as head of the consumer health business in 2007, I jumped at the chance.

Only a few short months after I started there, I was beyond surprised when I was tapped to run the company’s Pharmaceuticals Division.

At first, I said no. I didn’t feel I had the right background in science or medicine, and wondered how I could lead an organization that is focused on discovering, developing and ensuring access to innovative medicines, many of which could be life-saving for patients. But the board said that was OK. They said they wanted me to take the job because I had the experience with customers. The pharmaceutical market was beginning to change to be more focused on patients, their experiences with therapies, and the value our products deliver to people and those who pay for them. The company needed someone to think differently, and not be bound by what had worked in the past. Because in the future, we would need a totally different approach to succeed.

So, I took the job. I spent many, many hours learning about the industry, our products and pipeline, and the science behind it all. In fact, I even had a tutor come every morning at 7am to help me understand.

I quickly got the hang of it, and spent a lot of time helping the organization become more externally focused. I brought in patients to talk with our employees – seeking to step up the interactions we have with patients and highlight the impact our work has on the lives of real people. Over time, we have become a much more externally-focused organization, and we work hard at making sure that patients are at the center of all that we do.

Three years later, I was named CEO of Novartis, a position I’ve held for the last six years. I love what I do. It’s energizing to see our innovations reach patients who need them. It’s also very rewarding to see our people develop, to change as the industry shifts, and to never lose sight of the reason we come to work every day: to help patients.

Looking back, I can see now that the trajectory of my career changed when I accepted that board position. And I’m so glad that it did.

Zouchra Aikaterini Kasimova

AIIC Conference Interpreter, medical background ★ Russian - English and Russian - Greek

8 年

I am wondering how much of an outsider I am. A girl who studied medicine in Russia in the late 80's, moved to the West , became an international conference interpreter and has been working at innumerable medical and pharma conferences followin the latest developments in the industry. Well done, Joe!

回复
Deidra Parrish Williams

Dir. Global Corporate Social Responsibility & Community Affairs. Exec. Dir. Trane Technologies Foundation

8 年

Your story illustrates what more companies need to embrace -- the fact that innovation, passion and intelligence are transferable, and it's short-sighted to omit talented, but less obvious candidates from consideration. In the end, they can be tremendous assets, as you have proven.

回复
Christina Frintzilas

Administrative Assistant

8 年

Good read. Thank you! I am eager to read others.

回复
Gina Ore

Patient Experience Expert | Employee Engagement Facilitator - Founder & CEO, Passion for Patients

8 年

Great perspective - thanks for sharing.

回复
Paula Dunn

Clinical Team Manager | Innovator & Creator | Diversity, Equity & Inclusive leader | Cognitive Scientist | Best Selling Author | Global Keynote Speaker | Leadership Mentor | Certified Coach | Master NLP Practitioner

8 年

I'm at a cross road in my career and deciding on which route to take to expand my horizons. I am looking forward to what 2017 has to offer. Thank you for your insight on taking on a new challenge/direction.

要查看或添加评论,请登录

Joe Jimenez的更多文章

  • Addressing Population Health Amid The Covid-19 Pandemic

    Addressing Population Health Amid The Covid-19 Pandemic

    Of the many lessons to be learned from the COVID-19 pandemic, the staggering importance of population health is perhaps…

    3 条评论
  • Five Predictions of How Life Will Change After COVID-19

    Five Predictions of How Life Will Change After COVID-19

    Never before in human history has an event simultaneously impacted more people on the planet than COVID-19. Just as…

    23 条评论
  • Learning How to Lead

    Learning How to Lead

    Over my 30 years in management roles across many industries, one thing that I have studied intensely is how to motivate…

    31 条评论
  • The changing role of CEOs today

    The changing role of CEOs today

    Society’s expectations of corporations, and their leadership, have changed. In today’s social media age, the personal…

    31 条评论
  • How I see the future of business shifting

    How I see the future of business shifting

    Since leaving the helm of Novartis earlier this year, I’ve been spending a lot of time in California. It’s good to…

    21 条评论
  • How to manage through change and challenges

    How to manage through change and challenges

    They say that change is one of the only constants in life and in business. However when you’re faced with change…

    26 条评论
  • Reinvention after 10 years with Novartis

    Reinvention after 10 years with Novartis

    At the end of January, I moved on from Novartis after 10 great years, including eight as CEO. I feel privileged to have…

    60 条评论
  • Three trends that are changing the future of business

    Three trends that are changing the future of business

    For those of us in business, the New Year represents a good time to chart a course for success and analyze changes that…

    30 条评论
  • What’s next for healthcare: Opportunities at the intersection of biology and technology

    What’s next for healthcare: Opportunities at the intersection of biology and technology

    I recently returned from California where I attended the Laguna Biotech CEO Forum. The event gathered leaders from a…

    33 条评论
  • A new milestone in the fight against pediatric cancer

    A new milestone in the fight against pediatric cancer

    This week, Novartis received US FDA approval for our chimeric antigen receptor T cell (CAR-T) therapy that was…

    181 条评论

社区洞察

其他会员也浏览了